Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Healthy Adults × eltrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombocytopenia 8 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Purpura, Thrombocytopenic, Idiopathic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Jacobs syndrome 2 Sarcoma 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Healthy Volunteers 1 Healthy Adults 1 Blast Crisis 1

Interventions

eltrombopag 1 adagrasib 1 Peptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Mirati Therapeutics Inc.

Phase 1 Completed

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon ⚡